Translational Research
Volume 153, Issue 3 , Pages 132-141, March 2009

Acteylcholinesterase inhibitor rivastigmine enhances cellular defenses in neuronal and macrophage-like cell lines

Department of Medicine, Section of Geriatric Medicine, University of Illinois at Chicago, Jesse Brown VAMC, Chicago, Ill

Received 10 April 2008; received in revised form 4 December 2008; accepted 6 December 2008. published online 29 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by VA Research, the Vitoux Foundation, and an investigator-initiated grant from Novartis Pharmaceutical, Inc. with total investigator independence on the design and execution of the project.

PII: S1931-5244(08)00335-6

doi:10.1016/j.trsl.2008.12.003

Translational Research
Volume 153, Issue 3 , Pages 132-141, March 2009

Article Tools

* Image Usage & Resolution